DIA 2018 Global Annual Meeting

The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.

返回 Agenda

Global Evolution in Regulatory Science and Medicine: Novel Modalities and Intersection with Rare Disease Development

Session Chair(s)

Nina S. Cauchon, PHD

Director Regulatory Affairs CMC

Amgen, United States

We explore the rapid advancements in science and medicine leading to new complexities in the drug development ecosystem for rare diseases. Also, we examine and deliberate on the heterogeneous nature of regulatory frameworks globally for the treatment

Learning Objective : Discuss the intersection of precision medicine and rare disease drug development, including potential challenges; Explain, in general terms, about the global regulatory policy issues facing rare disease drug development.

DIA 2018 Global Annual Meeting

Global Evolution in Regulatory Science and Medicine: Novel Modalities and Intersection with Rare Disease Development

Session Chair(s)

Nina S. Cauchon, PHD

Learning Objective : Discuss the intersection of precision medicine and rare disease drug development, including potential challenges; Explain, in general terms, about the global regulatory policy issues facing rare disease drug development.

获得信息并保持参与